Ataxia Telangiectasia Presenting as Cervical Dystonia

Priyal Lnu1,2, Vineet Sehgal3, Saniya Kapila4

  • 1Neurology, Sehgal's Neuro and Child Care Centre, Amritsar, IND.

Cureus
|November 28, 2022
PubMed

Insights

A rare homozygous nonsense mutation in the ATM gene caused classic ataxia-telangiectasia in a pediatric patient presenting with movement disorders. Genetic testing is crucial for diagnosing A-T, especially in resource-limited settings.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Oncology

Background:

  • The Ataxia Telangiectasia Mutant (ATM) protein functions as a crucial sensor and signal transducer for DNA damage, initiating cellular responses like cell cycle arrest and apoptosis.
  • Classic Ataxia-Telangiectasia (A-T) is typically linked to homozygous mutations in the ATM gene, leading to a complete loss of its kinase activity.
  • Variant A-T cases may present with residual ATM kinase activity, indicating a spectrum of disease severity associated with ATM gene mutations.

Observation:

  • A six-year-old male patient presented with abnormal neck movements as the primary symptom.
  • ATM gene analysis revealed a rare homozygous nonsense mutation (p.Arg23Ter) in exon 2, causing premature protein truncation.
  • This specific mutation resulted in a complete loss of ATM kinase function.

Findings:

  • The study identified a novel homozygous nonsense mutation in the ATM gene in a pediatric patient with an unusual presentation of classic A-T.
  • The identified mutation led to a premature stop codon and a severely truncated ATM protein, consistent with loss of function.
  • The patient's clinical presentation, despite the severe mutation, highlights the complexity of genotype-phenotype correlations in A-T.

Implications:

  • This case underscores the importance of considering genetic testing, including pedigree analysis, for pediatric patients presenting with movement disorders, even with atypical symptoms.
  • In resource-limited settings, leveraging web-based mutation prediction tools can aid in assessing the pathogenicity of novel ATM variants when kinase assays are unavailable.
  • Long-term follow-up is essential for patients diagnosed with A-T to manage potential long-term health complications and monitor disease progression.

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
726
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
345
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
660